I-cell disease
(Redirected from Inclusion-cell disease)
Rare inherited metabolic disorder
I-cell disease | |
---|---|
[[File:|250px|alt=|]] | |
Synonyms | Mucolipidosis II |
Pronounce | |
Field | N/A |
Symptoms | Developmental delay, coarse facial features, skeletal abnormalities |
Complications | N/A |
Onset | Infancy |
Duration | Lifelong |
Types | N/A |
Causes | Genetic mutation in the GNPTAB gene |
Risks | |
Diagnosis | Clinical evaluation, genetic testing |
Differential diagnosis | Hurler syndrome, Hunter syndrome |
Prevention | N/A |
Treatment | Supportive care |
Medication | |
Prognosis | Poor |
Frequency | Rare |
Deaths | N/A |
I-cell disease, also known as mucolipidosis II, is a rare inherited metabolic disorder characterized by a deficiency in the enzyme required for the proper functioning of lysosomes. This condition is caused by mutations in the GNPTAB gene, which leads to the accumulation of certain substances within the cells, forming inclusion bodies, or "I-cells."
Signs and symptoms[edit | edit source]
Individuals with I-cell disease typically present with symptoms in infancy. These symptoms may include:
- Developmental delay
- Coarse facial features
- Skeletal abnormalities
- Growth retardation
- Enlarged liver and spleen (hepatosplenomegaly)
- Heart valve abnormalities
Cause[edit | edit source]
I-cell disease is caused by mutations in the GNPTAB gene, which encodes the enzyme N-acetylglucosamine-1-phosphotransferase. This enzyme is crucial for the proper tagging of lysosomal enzymes with mannose-6-phosphate, a marker that directs these enzymes to the lysosomes. Without this marker, lysosomal enzymes are misdirected outside the cell, leading to the accumulation of undigested substrates within the lysosomes.
Diagnosis[edit | edit source]
Diagnosis of I-cell disease is based on clinical evaluation and confirmed through genetic testing. Laboratory findings may show elevated levels of lysosomal enzymes in the blood and other body fluids, as these enzymes are not properly transported to the lysosomes.
Differential diagnosis[edit | edit source]
Conditions that may present similarly to I-cell disease and should be considered in the differential diagnosis include:
Treatment[edit | edit source]
There is currently no cure for I-cell disease. Treatment is primarily supportive and focuses on managing symptoms and improving the quality of life. This may include:
- Physical therapy
- Occupational therapy
- Surgical interventions for skeletal abnormalities
- Management of cardiac issues
Prognosis[edit | edit source]
The prognosis for individuals with I-cell disease is generally poor. Most affected individuals have a significantly shortened lifespan, often not surviving beyond early childhood due to complications such as respiratory infections and heart disease.
Related pages[edit | edit source]
- Lysosomal storage disease
- Hurler syndrome
- Hunter syndrome
- Mucolipidosis III
- Genetic mutation
- Inherited metabolic disorder
This article is a genetic disorder stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD